Trademark: 97882926
Word
PREVIOTOX
Status Date
Tuesday, May 21, 2024
Filing Date
Tuesday, April 11, 2023
Published for Opposition
Tuesday, May 21, 2024
5 Specimen collection kits for the collection of saliva for use in DNA screening and genetic testing for medical purposes comprised primarily of swabs for medical purposes and also including collection tubes with caps, all with or without stabilizing reagents and with instructions, printed mailing labels and flat pack cardboard mailing boxes; DNA collection kit comprised of DNA collection laboratory swab and swab handle for medical purposes
44 Medical and laboratory analysis in connection with the treatment of patients; Processing medical test kits and home sample collection kits; medical testing of saliva and blood; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes; medical testing for predicting toxicity in connection with immunotherapy treatments; Medical consultancy services; Medical risk assessment services in the nature of predicting toxicity in connection with immunotherapy treatments
10 Anatomic pathology specimen collection kits for use in genetic testing comprised primarily of saliva and blood collection containers for medical purposes sold empty, printed instructions, printed shipping labels and transport packaging; Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Medical diagnostic apparatus for testing and analysis of DNA and genetic samples for medical purposes; Medical specimen collection devices in the nature of empty tubes and vials for the collection of DNA samples for use in medical testing and analysis of genetics; Saliva collection devices for medical purposes
42 Scientific research services, namely, DNA screening and genetic testing; medical research services, namely, DNA screening and genetic testing; Medical laboratory testing services; medical and scientific research in the field of genetics and DNA analysis; scientific research and development services relating to predicting toxicity in connection with immunotherapy treatments; research and development for the purpose of determining treatment selection in the field of immune oncology; providing scientific and medical research information in the field of genetics and DNA analysis
Apr 14, 2023
New Application Entered
May 5, 2023
New Application Office Supplied Data Entered
Jan 8, 2024
Assigned To Examiner
Jan 8, 2024
Non-Final Action Written
Jan 8, 2024
Non-Final Action E-Mailed
Jan 8, 2024
Notification Of Non-Final Action E-Mailed
Apr 1, 2024
Teas Response To Office Action Received
Apr 1, 2024
Correspondence Received In Law Office
Apr 1, 2024
Teas/Email Correspondence Entered
May 1, 2024
Notification Of Notice Of Publication E-Mailed
May 21, 2024
Published For Opposition
May 21, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 15, 2024
Approved For Pub - Principal Register
Trademark Alertz updated from USPTO on 2030-01-24
